FRESH-PEF60076-en
Primary infection cohort
ANRS CO6 PRIMO
| Name | Country code |
|---|---|
| France | fr |
['Clinical data','Biological data','Participant-reported health data']
Individuals
| Topic | Vocabulary |
|---|---|
| Infectious disease medicine | health theme |
| Human immunodeficiency virus disease without mention of tuberculosis or malaria | cim-11 |
| Socio-demographic and economic determinants | health determinant |
| Environmental determinants: Other | health determinant |
| Behavioral determinants | health determinant |
| Healthcare system determinants: Use of care | health determinant |
| Environmental determinants | health determinant |
| Healthcare system determinants | health determinant |
{"level_sex_clusion_I":[{"value":"Male","concept":{"vocab":"MeSH","vocabURI":"D008297"}},{"value":"Female","concept":{"vocab":"MeSH","vocabURI":"D005260"}},{"value":"Other","concept":{"vocab":[],"vocabURI":[]}}],"level_age_clusion_I":[{"value":"Young Adult (19 to 24 years)","concept":{"vocab":"MeSH","vocabURI":"D055815"}},{"value":"Adult (25 to 44 years)","concept":{"vocab":"MeSH","vocabURI":"D000328"}},{"value":"Middle Aged (45 to 64 years)","concept":{"vocab":"MeSH","vocabURI":"D008875"}},{"value":"Aged (65 to 79 years)","concept":{"vocab":"MeSH","vocabURI":"D000368"}},{"value":"Aged, 80 and over (80 years and more)","concept":{"vocab":"MeSH","vocabURI":"D000369"}}],"level_type_clusion_I":"Patients population","level_type_clusion_other":"","clusion_I":"1) symptomatic or asymptomatic HIV-1 primary infection. 2) Infection date based on one of the following criteria: incomplete Western Blot; or positive p24 antigenemia/detectable plasma HIV RNA along with a negative or weakly positive ELISA or a negative or undetermined Western Blot, or a negative ELISA within the three previous months. 3) Enrollment within a maximum of 3 months after the estimated infection date. 4) Naive of antiretroviral treatment except for transient treatment taken in the context of PMTCT, PrEP or PEP.","clusion_E":""}
| Name |
|---|
| Cécile;GOUJARD |
| Asma;ESSAT |
| Laurence;MEYER |
| Name | Role |
|---|---|
| AGENCE NATIONALE DE RECHERCHES SUR LE SIDA ET LES HEPATITES VIRALES (ANRS MIE) | sponsor |
| INSTITUT NATIONAL DE LA SANTE ET DE LA RECHERCHE MEDICALE (INSERM) | sponsor |
| Name |
|---|
| AGENCE NATIONALE DE RECHERCHES SUR LE SIDA ET LES HEPATITES VIRALES (ANRS MIE) |
| Agency name |
|---|
| CNIL |
| CPP |
['Through organizations (health services or institutions, schools, businesses, etc.)']
['{"concept":{"vocabURI":"Other","vocab":"CESSDA"},"value":"Other"}']
Access on specific project only
Observational Study
| Start | End |
|---|---|
| 1996-01-01 | 2022-01-01 |
{"value":"Restricted access","extLink":[{"title":"COAR","uri":"http://purl.org/coar/access_right/c_16ec"}]}
data available to academic teams
| Name | |
|---|---|
| Cécile;GOUJARD | cecile.goujard@aphp.fr |
| Laurence;MEYER | laurence.meyer@inserm.fr |